Immunogenicity 11316

summary
Sample ID
3775
Response
Negative
Tumor Type
Cervical Carcinoma(HPV+)
Gene Symbol
GPALPP1
Transcript ID
uc001uzr.1
HLA INFO
A*24:02
TCR INFO

No TCR info found!

T cell Tumor cell A*24:02
sequence
Full length protein sequence (340 aa)
MARDL
1
IGPAL
6
PPGFK
11
ARGTA
16
EDEER
21
DPSPV
26
AGPAL
31
PPNYK
36
SSSSD
41
SSDSD
46
EDSSS
51
LYEEG
56
NQESE
61
EDDSG
66
PTARK
71
QRKNQ
76
DDDDD
81
DDDGF
86
FGPAL
91
PPGFK
96
KQDDS
101
PPRPI
106
IGPAL
111
PPGFI
116
KSTQK
121
SDKGR
126
DDPGQ
131
QETDS
136
SEDED
141
IIGPM
146
PAKGP
151
VNYNV
156
TTEFE
161
KRAQR
166
MKEKL
171
TKGDD
176
DSSKP
181
IVRES
186
WMTEL
191
PPEMK
196
DFGLG
201
PRTFK
206
RRADD
211
TSGDR
216
SIWTD
221
TPADR
226
ERKAK
231
ETQEA
236
RKSSS
241
KKDEE
246
HILSG
251
RDKRL
256
AEQVS
261
SYNES
266
KRSES
271
LMDIH
276
HKKLK
281
SKAAE
286
DKNKP
291
QERIP
296
FDRDK
301
DLKVN
306
RFDEA
311
QKKAL
316
IKKSR
321
ELNTR
326
FSHGK
331
GNMFL
336
Mutation Information
DNA mutation:
None
Peptide Range:
62 ~ 86
Mut AA position:
74 (13 in Wild Type peptide)
Alignment
Wild Type:
"QESEEDDSGPTARKQRKNQDDDDDD
||||||||||||.||||||||||||
Mutant:
QESEEDDSGPTAIKQRKNQDDDDDD"
reference
clinic trial
Checkpoint Blockade

None

ACT

None

Vaccination

None

Curative Effect

None

experiment
minimal_peptide

None

Antigen Type

TMG RNA

T-cell Source

TILs

APC Type

autologous DCs

Assay

IFNg ELISPOT assay